Chronic Immune Thrombocytopentic Purpura in Children: Assessment of Rituximab Treatment

Bay, A2025-05-102025-05-1020060022-34761097-683310.1016/j.jpeds.2005.10.0262-s2.0-33645977753https://doi.org/10.1016/j.jpeds.2005.10.026https://hdl.handle.net/20.500.14720/12210eninfo:eu-repo/semantics/openAccessChronic Immune Thrombocytopentic Purpura in Children: Assessment of Rituximab Treatment - To the EditorLetter1483Q1Q142342416615987WOS:000236718700039